+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Facial Injectable Market Size, Share & Trends Analysis Report by Product (Collagen, Hyaluronic Acid, Botulinum Toxin Type A, Calcium Hydroxylapatite, Polymer Fillers), by Application (Aesthetic, Therapeutic), by Region, and Segment Forecasts 2022-2030

  • ID: 4312576
  • Report
  • April 2022
  • Region: Global
  • 172 Pages
  • Grand View Research

FEATURED COMPANIES

  • Allergan
  • Anika Therapeutics, Inc.
  • Bloomage Biotechnology
  • Galderma S.A.
  • Ipsen
  • Medytox
The global facial injectable market size is expected to reach USD 35.0 billion by 2030. The market is expected to register a CAGR of 9.1% from 2022 to 2030. The facial injectable is a substance that is used to reduce wrinkles and restore volume and fullness in the face. It is injected beneath the facial skin surface. Some commonly used facial injectable include hyaluronic acid, botulinum toxin type A, and polymer fillers.



Growing focus on physical appearance, especially in developing countries is one of the key factors expected to drive the market. In addition, a shift in consumer preference towards minimally invasive procedures is also expected to support market growth. According to the American Society of Plastic Surgeons (ASPS), in 2020, botulinum toxin A and soft tissue fillers were among the top 5 minimally invasive procedures carried out in the U.S. Thus, facial injectable holds high growth prospects in the years to come.

In Asia Pacific, the market is expected to serve as a key revenue-generating center. The region is backed by countries such as India, where a growing focus on physical appearance is expected to create a lucrative opportunity for the market. Companies such as Allergan are also expanding their presence in the country owing to the rise in the number of middle-class populations backed by increasing disposable income.

The onset of the pandemic led to nonurgent and cosmetic surgeries being put on hold in the first and second quarters of 2020. However, the later months witnessed high demand for aesthetic consultations and procedures as patients were willing to undergo cosmetic treatments now more than ever due to high disposable income and desire to look appealing on zoom calls and online meetings.

Facial Injectable Market Report Highlights

  • The botulinum toxin type A segment is projected to dominate the market throughout the forecast period. It is one of the most popularly used minimally invasive procedures.
  • The aesthetic segment is projected to grow fast over the forecast period owing to the rise in the use of facial injectables for aesthetic procedures such as the treatment of wrinkles on the face.
  • North America dominated the market with a revenue share of 41.0% IN 2021 owing to the easy availability of the products and the presence of a large number of skilled surgeons.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Facial Injectable Market

What is the estimated value of the Global Facial Injectable Market?

The Global Facial Injectable Market was estimated to be valued at $17.4 Billion in 2022.

What is the growth rate of the Global Facial Injectable Market?

The growth rate of the Global Facial Injectable Market is 9.1%, with an estimated value of $35.0 Billion by 2030.

What is the forecasted size of the Global Facial Injectable Market?

The Global Facial Injectable Market is estimated to be worth $35.0 Billion by 2030.

Who are the key companies in the Global Facial Injectable Market?

Key companies in the Global Facial Injectable Market include Allergan, Ipsen, Merz Pharma GmbH & Co. Kgaa, Suneva Medical, Inc., Sinclair Pharma, Bloomage Biotechnology, Anika Therapeutics, Inc., Prollenium Medical Technologies Inc. and Medytox.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Allergan
  • Anika Therapeutics, Inc.
  • Bloomage Biotechnology
  • Galderma S.A.
  • Ipsen
  • Medytox

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
Chapter 3. Facial InjecTable Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Facial injecTable: Market Analysis Tools
3.4.1. Industry Analysis-Porter’s
3.4.1.1. Supplier Power
3.4.1.2. Buyer Power
3.4.1.3. Substitution Threat
3.4.1.4. Threat from new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political Landscape
3.4.2.2. Environmental Landscape
3.4.2.3. Social Landscape
3.4.2.4. Technology Landscape
3.4.2.5. Legal Landscape
3.4.3. Major Deals & Strategic Alliances Analysis
Chapter 4. Facial InjecTable Market: Segment Analysis, by Product, 2018-2030 (USD Million)
4.1. Segment Dashboard
4.2. Product Market Share Analysis, 2022 & 2030
4.3. Global Facial InjecTable Market, by product, 2018 to 2030
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Collagen
4.6. Hyaluronic Acid (HA)
4.7. Botulinum Toxin Type A
4.8. Calcium Hydroxylapatite (CaHA)
4.9. Polymer Fillers
4.9.1.1. Polymethylmethacrylate beads (PMMA Microspheres)
4.9.1.2. Poly-L-Lactic Acid (PLLA)
Chapter 5. Facial InjecTable Market: Segment Analysis, by Application, 2018-2030 (USD Million)
5.1. Segment Dashboard
5.2. Category Market Share Analysis, 2022 & 2030
5.3. Global Facial injecTable Market, by Application, 2018 to 2030
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Aesthetics
5.4.2. Therapeutics
Chapter 6. Facial InjecTable Market: Regional Market Analysis, by Region, 2018-2030 (USD Million)
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2022 & 2030
6.3. Market Size, & Forecasts, and Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. Market estimates and forecast, by country, 2018-2030 (USD Million)
6.4.2. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.4.3. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.4.4. U.S.
6.4.4.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.4.4.2. Market estimates and forecast, by application, 2018-2030 (USD Million
6.4.5. Canada
6.4.5.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.4.5.2. Market estimates and forecast, by application, 2018-2030 (USD Million
6.5. Europe
6.5.1. Market estimates and forecast, by country, 2018-2030 (USD Million)
6.5.2. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.5.3. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.5.4. Germany
6.5.4.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.5.4.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.5.5. U.K.
6.5.5.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.5.5.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.5.6. France
6.5.6.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.5.6.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.5.7. Italy
6.5.7.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.5.7.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.5.8. Spain
6.5.8.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.5.8.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.5.9. Switzerland
6.5.9.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.5.9.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.5.10. Netherland
6.5.10.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.5.10.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.5.11. Belgium
6.5.11.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.5.11.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.6. Asia Pacific
6.6.1. Market estimates and forecast, by country, 2018-2030 (USD Million)
6.6.1.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.6.1.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.6.2. China
6.6.2.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.6.2.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.6.3. Japan
6.6.3.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.6.3.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.6.4. India
6.6.4.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.6.4.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.6.5. Australia
6.6.5.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.6.5.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.6.6. South Korea
6.6.6.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.6.6.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.6.7. Malaysia
6.6.7.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.6.7.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.6.8. Singapore
6.6.8.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.6.8.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.6.9. Indonesia
6.6.9.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.6.9.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.6.10. Philippines
6.6.10.1. Market estimates and forecast, by Product, 2018-2030 (USD Million)
6.6.10.2. Market estimates and forecast, by Application, 2018-2030 (USD Million)
6.7. Latin America
6.7.1. Market estimates and forecast, by country, 2018-2030 (USD Billion)
6.7.1.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.7.1.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.7.2.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.7.3. Mexico
6.7.3.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.7.3.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.7.4. Argentina
6.7.4.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.7.4.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.7.5. Colombia
6.7.5.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.7.5.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.7.6. Chile
6.7.6.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.7.6.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.8. Middle East and Africa
6.8.1. Market estimates and forecast, by country, 2018-2030 (USD Billion)
6.8.1.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.8.1.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.8.2.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.8.3.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.8.4. UAE
6.8.4.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.8.4.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.8.5. Israel
6.8.5.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.8.5.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
6.8.6. Turkey
6.8.6.1. Market estimates and forecast, by product, 2018-2030 (USD Million)
6.8.6.2. Market estimates and forecast, by application, 2018-2030 (USD Million)
Chapter 7. Facial InjecTable Market-Competitive Analysis
7.1. Key companies profiled
7.1.1 Allergan
7.1.1.1. Company Overview
7.1.1.2. Financial Performance
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. Ipsen
7.1.2.1. Company Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. Merz Pharma GmbH & Co. KGaA
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. Suneva Medical, Inc.
7.1.4.1. Company Overview
7.1.4.2. Financial Performance
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. Sinclair Pharma
7.1.5.1. Company Overview
7.1.5.2. Financial Performance
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. Bloomage BioTechnology
7.1.6.1. Company Overview
7.1.6.2. Financial Performance
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. Anika Therapeutics, Inc.
7.1.7.1. Company Overview
7.1.7.2. Financial Performance
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. Prollenium Medical Technologies Inc.
7.1.8.1. Company Overview
7.1.8.2. Financial Performance
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. Galderma S.A.
7.1.9.1. Company Overview
7.1.9.2. Financial Performance
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. Medytox
7.1.10.1. Company Overview
7.1.10.2. Financial Performance
7.1.10.3. Product Benchmarking
7.1.10.4. Strategic Initiatives
Note: Product cover images may vary from those shown
  • Allergan
  • Ipsen
  • Merz Pharma GmbH & Co. Kgaa
  • Suneva Medical, Inc.
  • Sinclair Pharma
  • Bloomage Biotechnology
  • Anika Therapeutics, Inc.
  • Prollenium Medical Technologies Inc.
  • Galderma S.A.
  • Medytox
Note: Product cover images may vary from those shown

Loading
LOADING...